Just this morning after Lilly reported we spent some serious time explaining the complexities of the insulin pump market. Thankfully for Lilly the one path they have chosen not to follow in the device arena is developing one of these stupid patch pumps. Unlike a real insulin pump these systems deliver a preset dose of insulin and have the ability with the touch of button to deliver additional units.
The theory behind all of these projects is that patients following multiple daily injection (MDI) therapy will only have to stick themselves once every three days rather than multiple times per . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.